Idarubicin (Intravenous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Idarubicin (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Idamycin PFS

Description

Idarubicin belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancer, including leukemia.

Idarubicin seems to interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by idarubicin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.

Before you begin treatment with idarubicin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.

Idarubicin is to be administered only by or under the supervision of your doctor.

Before Using
DR600771 Portions of this document last updated: Nov. 1, 2011

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger